FDMT

4D Molecular Therapeutics Inc.

Price

$16.76

return (12m)

155.10%

p/e

-4.52

p/bv

1.99

DIVIDEND YIELD

0.00%

FDMT price

4D Molecular Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment FDMT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

43.37%

3 months

92.87%

1 year

155.10%

2 years

13.94%

5 years

-42.86%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals FDMT

Valuation

P/E

-4.52

Sector -4.38

Industry -4.38

P/BV

1.99

Sector 2.02

Industry 2.02

P/Revenue (PSR)

8.81

Sector -4.40

Industry -4.40

EV/EBITDA

-6.26

Sector -263.09

Industry -263.09

EV/EBIT

-6.09

Sector -702.90

Industry -702.90

P/EBITDA

-4.29

Sector -4.39

Industry -4.39

P/EBIT

-4.11

Sector -4.73

Industry -4.73

P/Total Assets

1.65

Sector 1.49

Industry 1.49

P/Net Current Assets

2.72

Sector -11.70

Industry -11.70

P/Working Capital

2.42

Sector -3.19

Industry -3.19

EPS

-2.56

Sector -2.14

Industry -2.14

BVPS

5.82

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-1,982.54%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-2,037.83%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.01

Sector 0.03

Industry 0.03

Profitability

ROE

-43.95%

Sector -65.14%

Industry -65.14%

ROA

-36.37%

Sector -65.53%

Industry -65.53%

ROIC

-264.73%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

8.03

Sector 2.90

Industry 2.90

Net Debt / EBITDA

4.56

Sector -6.07

Industry -6.07

Net Debt / EBIT

4.44

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.84

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.05

Sector -0.05

Industry -0.05

Equity/Assets

0.83

Sector 0.41

Industry 0.41

Liabilities/Assets

0.17

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

38.52%

Sector -

Industry -

5Y Earnings CAGR

20.23%

Sector -

Industry -

Fundamentals FDMT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
FDMT 4D Molecular Therapeutics Inc.	$16.76	130.54%	0.00%	-4.52	1.99	-43.95%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

FDMT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT 4D Molecular Therapeutics

4D Molecular Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2020

Time since IPO - 6 years

83

Employees

4D Molecular Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $810.60 million, with shareholders equity totaling $407.66 million.

The company employs approximately 83 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, 4D Molecular Therapeutics Inc. reported $92.01 million in revenue, generating net income of $-179.18 million.

Key financial metrics include a P/E ratio of -4.52, a price-to-book (P/B) ratio of 1.99, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker FDMT.

Market cap

$810.60 million

Net worth

$407.66 million

$407,660,000.00

Assets

$492.62 million

$492,620,000.00

Total Shares Outstanding

70.00 million

70,000,000

Average Daily Trading Volume

$835.01 Thousand

$835,008.00

Sector

Health Care

Industry

Biotechnology

FDMT

FDMT revenue and profits

Financial Results FDMT

DRAG THE FRAME TO SEE MORE DATA

FDMT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of 4D Molecular Therapeutics (FDMT) today?

A cotação de 4D Molecular Therapeutics (FDMT) hoje está em US$ 16.76, com uma variação de 155.1% em relação ao último ano. A cotação de 4D Molecular Therapeutics (FDMT) iniciou o ano negociando na casa dos US$ 7.50 e hoje está em US$ 16.76. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de 4D Molecular Therapeutics (FDMT) e dados de ações do Ibovespa e mercados internacionais.

Quando 4D Molecular Therapeutics (FDMT) paga dividendos?

4D Molecular Therapeutics (FDMT) não distribuiu dividendos no último ano.

Is 4D Molecular Therapeutics (FDMT) a good investment?

Atualmente, 4D Molecular Therapeutics (FDMT) está cotada a US$ 16.76, com um P/L de -4.52, representando um desvio de -502% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 155.1 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 155.10%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy 4D Molecular Therapeutics (FDMT) stock?

Investir em ações de 4D Molecular Therapeutics (FDMT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of 4D Molecular Therapeutics (FDMT) yield today?

A rentabilidade de 4D Molecular Therapeutics (FDMT) foi de 43.37% no último mês, 155.10% no último ano e -42.86% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de 4D Molecular Therapeutics (FDMT) hoje, o investimento total seria de US$ 1,676.00, com base na cotação atual de US$ 16.76.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 4,275.48
Em 5 anos: US$ 957.67
Em 10 anos: US$ 1,676.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

FDMT

4D Molecular Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment FDMT

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING FDMT WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT 4D Molecular Therapeutics

4D Molecular Therapeutics Inc.

United States

11 years

2020

83

PROFIT X PRICE FDMT

Financial Results FDMT

FDMT cash flow

Asset, Revenue and Profit Growth - FDMT

FDMT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions